Keitma / Shutterstock.com
French drugmaker Sanofi is looking to create a new European manufacturer of active pharmaceutical ingredients (APIs), amid concerns over dependence on a Chinese manufacturing sector hit by coronavirus.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Sanofi, coronavirus, COVID-19, APIs, active pharmaceutical ingredients, China, France, drug supply, US Food and Drug Administration, FDA
